Potential Nosocomial Infection Prevention Via Modification of Anesthesia Intraoperative Aseptic Practice

Nosocomial Infections Clinical Trial

Official title:

Before and After Study Evaluating Deployment of the Sprixx GJ Personal Hand Hygiene Device in the Intra-Operative Environment

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00617006
• Other study ID #: CPHS# 20655
• Status: Completed
• Phase: N/A
• First received: February 5, 2008
• Last updated: February 14, 2008
• Start date: July 2007
• Est. completion date: October 2007

Study information

• Verified date: February 2008
• Source: Dartmouth-Hitchcock Medical Center
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Observational

Clinical Trial Summary

We hypothesized that by improving hand hygiene compliance in the operative environment, we would reduce horizontal transmission of pathogenic bacteria to surgical patients.

Description:

We performed an observational study evaluating provider adherence to these techniques. We then sought to increase hand hygiene compliance through the use of a point of care alcohol based hand hygiene device. We hypothesized that increased hand hygiene compliance would reduce bacterial contamination of the anesthesia workspace and peripheral intravenous tubing, and ultimately reducing overall morbidity and mortality secondary to a reduction in nosocomial infection rates.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 114
• Est. completion date: October 2007
• Est. primary completion date: August 2007
• Accepts healthy volunteers: No
• Gender: Both
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• Patients present in operating rooms randomized to study.

Exclusion Criteria:

• Patients that were already enrolled in study and return to the operating room.

Study Design

Observational Model: Ecologic or Community, Time Perspective: Prospective

Related Conditions & MeSH terms

• Cross Infection
• Infection
• Nosocomial Infections

Locations

Country	Name	City	State
United States	Dartmouth-Hitchcock Medical Center	Lebanon	New Hampshire

Sponsors (3)

Lead Sponsor	Collaborator
Dartmouth-Hitchcock Medical Center	Dartmouth-Hitchcock Quality Improvement Foundation (Research Funding), Harbor Medical Inc.

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	The presence of a positive culture on the previously sterile patient stopcock set, and the presence of multidrug resistant bacteria		Beginning and end of surgical case	Yes
Secondary	Reduction of bacterial contamination on predetermined sites on the anesthesia machine		Beginning and End of Surgical Case	Yes
Secondary	Decreased length of stay		Postoperatively	Yes
Secondary	Nosocomial infection rates		within 30 days postoperatively	Yes
Secondary	Mortality		Within 30 days postoperatively	Yes